SARS-CoV-2 lso2 Lin B.1.526_2021 lota (NYWadsworth-21025952-01/2021) – CFHI

SARS-Related Coronavirus 2 Lineage B.1.526_2021; Iota Variant (Isolate: USA/NY-Wadsworth-21018781- 01/2021 Isolate 2) is an enveloped, positive-sense single-stranded RNA virus from the Coronaviridae family and the Betacoronaviridae genus. SARS-CoV-2 isolate USA/NY-Wadsworth-21018781- 01/2021 Isolate 2 was collected in February 2021 in New York, USA. Under the nomenclature system introduced by GISAID (Global Initiative on Sharing All Influenza Data), SARS-CoV-2, isolate USA/NY-Wadsworth-21018781- 01/2021 Isolate 2 is assigned lineage B.1.526. It was labelled as Iota variant by the World Health Organization (WHO). The complete genome of USA/NY-Wadsworth- 21018781-01/2021 Isolate 2 has been sequenced (GISAID: EPI_ISL_1227227). Each frozen aliquot contains 1 mL of heat inactivated viral culture fluid. The re-inactivation titer was determined from an infectious aliquot. Viral inactivation is verified after heat inactivation by the absence of viral growth in tissue culture-based infectivity assays.

Heat inactivated viral culture fluids are sold as consumable testing materials. The suitability and performance characteristics should be determined by your laboratory for each intended usage. These products are NOT intended for use in the manufacture or processing of injectable products subject to licensure under section 351 of the Public Health Service Act or for any other product intended for administration to humans.

For BSL-2 or BSL-3 compliant labs only. CCL required / -20° C.
Product Insert.pdf

Material Safety Data Sheet.pdf